Clinical Research and Trials in Cardiorenal Syndromes: Pathophysiology, Real-World Evidence, and Patient Outcomes

Special Issue Information

Dear Colleagues,

Cardiorenal syndromes represent a complex and bidirectional interaction between the heart and kidneys, characterized by shared pathophysiological mechanisms and interdependent clinical outcomes. These conditions are increasingly recognized as a major global health burden, contributing significantly to morbidity, mortality, and healthcare utilization worldwide.

Despite advances in cardiovascular and renal medicine, managing cardiorenal syndromes remains challenging due to their multifactorial nature, involving hemodynamic alterations, neurohormonal activation, systemic inflammation, endothelial dysfunction, and metabolic disturbances. Patients with concurrent cardiac and renal dysfunction often experience accelerated disease progression, increased hospitalization rates, and poor long-term prognosis.

In recent years, clinical research and trials have significantly advanced our understanding of cardiorenal interactions, particularly through large-scale outcome studies and real-world evidence. Novel therapeutic agents such as SGLT2 inhibitors and other cardiometabolic therapies have demonstrated important benefits in improving both cardiac and renal outcomes, reshaping treatment paradigms in this high-risk population.

Contemporary research is increasingly focused on identifying biomarkers, elucidating molecular and cellular pathways, and improving risk stratification strategies to enable earlier intervention and personalized treatment approaches. Translational studies are also providing valuable insights into the mechanisms underlying disease progression, including oxidative stress, inflammation, and neurohormonal dysregulation. In parallel, real-world data are helping to validate clinical trial findings and optimize treatment strategies in routine clinical practice.

Building on ongoing progress in cardiovascular and renal research, this Special Issue aims to further advance knowledge in the field of cardiorenal syndromes, with a focus on pathophysiology, clinical outcomes, and translational insights. We welcome original research articles, systematic reviews, meta-analyses, and clinical trial reports that contribute to improving patient care and long-term outcomes.

We particularly encourage submissions that explore:

• Pathophysiological mechanisms of cardiorenal syndromes
• Real-world evidence in cardiovascular and renal outcomes
• Biomarkers for early detection and prognosis
• Therapeutic strategies targeting cardiorenal interactions
• Clinical outcomes of novel cardiometabolic therapies
• Risk prediction models and personalized treatment approaches

We invite researchers, clinicians, and scientists to contribute high-quality manuscripts that will advance understanding and innovation in this important interdisciplinary field.

Guest Editor
Dr. Samer Ellahham

Manuscript Submission Information

Manuscripts should be submitted online through the journal submission system by registering and logging into the website. Once registered, authors may access the submission portal directly. Submissions are accepted until the stated deadline. All manuscripts that pass initial editorial screening will undergo a rigorous peer-review process.

Accepted articles will be published continuously upon acceptance and will be listed collectively on the Special Issue webpage. We welcome original research articles, comprehensive reviews, and short communications. Authors intending to submit planned papers may send a title and abstract (approximately 250 words) to the Editorial Office for preliminary evaluation.

Submitted manuscripts must be original, not previously published, and not under consideration elsewhere (except conference proceedings). All submissions are subject to a single-blind peer-review process. Detailed author guidelines are available on the Instructions for Authors page.

We encourage authors to ensure clear scientific writing and proper formatting prior to submission. Language editing services may be used to improve manuscript quality if needed.

We look forward to your valuable contributions to this Special Issue.

Benefits

Benefits of Publishing in a Special Issue

Publishing in a Special Issue offers several important advantages for authors and researchers, enhancing both the visibility and impact of their scientific work.

Improved focus and ease of navigation:
By grouping articles under a clearly defined thematic area, Special Issues help readers and researchers navigate broad-scope journals more efficiently and locate relevant studies within their field of interest.

Increased visibility and discoverability:
Special Issues significantly improve the reach of published research. Articles featured in them are more easily discovered by the scientific community and often receive higher citation rates compared to standard publications.

Enhanced research networking opportunities:
Contributing to a Special Issue encourages interaction among authors working on related topics, helping to build new collaborations and strengthen professional research networks across institutions and disciplines.

Broader promotional support:
Articles published in Special Issues are frequently highlighted and promoted through the journal’s communication channels, including social media platforms, thereby increasing readership and academic exposure.

Reprint and extended dissemination opportunities:
Selected Special Issues may be republished in book format through MDPI Books, available in both online and print editions, further extending the reach and long-term accessibility of the research.

For additional details regarding Special Issue policies and publication guidelines, please refer to the journal’s official information page.